ATE519502T1 - Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzen - Google Patents
Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzenInfo
- Publication number
- ATE519502T1 ATE519502T1 AT04701730T AT04701730T ATE519502T1 AT E519502 T1 ATE519502 T1 AT E519502T1 AT 04701730 T AT04701730 T AT 04701730T AT 04701730 T AT04701730 T AT 04701730T AT E519502 T1 ATE519502 T1 AT E519502T1
- Authority
- AT
- Austria
- Prior art keywords
- abuse
- substance
- preventing
- controlled substance
- controlled substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Paper (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43946803P | 2003-01-13 | 2003-01-13 | |
PCT/US2004/000646 WO2004062614A2 (en) | 2003-01-13 | 2004-01-13 | Carbohydrate conjugates to prevent abuse of controlled substances |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE519502T1 true ATE519502T1 (de) | 2011-08-15 |
Family
ID=32713487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04701730T ATE519502T1 (de) | 2003-01-13 | 2004-01-13 | Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1594513B1 (de) |
JP (1) | JP2006515622A (de) |
KR (1) | KR20050098246A (de) |
CN (1) | CN1747737A (de) |
AT (1) | ATE519502T1 (de) |
AU (1) | AU2004204804C1 (de) |
CA (1) | CA2512951A1 (de) |
ES (1) | ES2371462T3 (de) |
IL (1) | IL169645A0 (de) |
WO (1) | WO2004062614A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004110255A2 (en) | 2003-06-09 | 2004-12-23 | Gang Zheng | Antineoplastic agents targeted via glut transporters |
SG172633A1 (en) * | 2006-05-26 | 2011-07-28 | Pharmacofore Inc | Controlled release of phenolic opioids |
AU2008338207A1 (en) | 2007-12-17 | 2009-06-25 | Labopharm (Barbados) Limited | Misuse preventative, controlled release formulation |
CA2746888C (en) | 2008-12-16 | 2015-05-12 | Labopharm (Barbados) Limited | Misuse preventative, controlled release formulation |
EP3355885A4 (de) | 2015-10-01 | 2019-04-24 | Elysium Therapeutics, Inc. | Mehrfachuntereinheit-opioid-prodrugs mit resistenz gegen überdosierung und missbrauch |
US10335406B2 (en) | 2015-10-01 | 2019-07-02 | Elysium Therapeutics, Inc. | Opioid compositions resistant to overdose and abuse |
EP3595663A4 (de) | 2017-03-17 | 2021-01-13 | Elysium Therapeutics, Inc. | Mehrfachuntereinheit-opioid-prodrugs mit resistenz gegen überdosierung und missbrauch |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130205A1 (en) * | 2000-04-12 | 2003-07-10 | Christian Samuel T. | Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use |
US6548484B1 (en) * | 2000-04-12 | 2003-04-15 | International Medical Innovations, Inc. | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
US20020099013A1 (en) * | 2000-11-14 | 2002-07-25 | Thomas Piccariello | Active agent delivery systems and methods for protecting and administering active agents |
EP1325014B1 (de) * | 2000-09-22 | 2012-05-23 | JPI Commercial, LLC | Gamma-hydroxybutyratzusammensetzungen mit kohlenhydratträger |
AU2002313628A1 (en) * | 2001-05-22 | 2002-12-03 | Euro-Celtique | Tamper resistant oral dosage form |
US6713452B2 (en) * | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
CA2472917A1 (en) * | 2002-01-08 | 2003-07-17 | New River Pharmaceuticals Inc. | Dendritic encapsulation of active agents |
AU2003219863C1 (en) * | 2002-02-22 | 2009-03-05 | Shire Llc | Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances |
EP2959893A1 (de) * | 2002-12-13 | 2015-12-30 | DURECT Corporation | Orales arzneimittelverabreichungssystem mit hochviskosen flüssigkeitsträgermaterialien |
-
2004
- 2004-01-13 AT AT04701730T patent/ATE519502T1/de not_active IP Right Cessation
- 2004-01-13 WO PCT/US2004/000646 patent/WO2004062614A2/en active Application Filing
- 2004-01-13 AU AU2004204804A patent/AU2004204804C1/en not_active Ceased
- 2004-01-13 KR KR1020057012951A patent/KR20050098246A/ko not_active Application Discontinuation
- 2004-01-13 CN CNA2004800040107A patent/CN1747737A/zh active Pending
- 2004-01-13 JP JP2006500902A patent/JP2006515622A/ja active Pending
- 2004-01-13 EP EP04701730A patent/EP1594513B1/de not_active Expired - Lifetime
- 2004-01-13 ES ES04701730T patent/ES2371462T3/es not_active Expired - Lifetime
- 2004-01-13 CA CA002512951A patent/CA2512951A1/en not_active Abandoned
-
2005
- 2005-07-12 IL IL169645A patent/IL169645A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050098246A (ko) | 2005-10-11 |
EP1594513A4 (de) | 2009-02-04 |
JP2006515622A (ja) | 2006-06-01 |
EP1594513B1 (de) | 2011-08-10 |
ES2371462T3 (es) | 2012-01-03 |
WO2004062614A2 (en) | 2004-07-29 |
CA2512951A1 (en) | 2004-07-29 |
WO2004062614A3 (en) | 2005-05-06 |
AU2004204804A1 (en) | 2004-07-29 |
IL169645A0 (en) | 2007-07-04 |
CN1747737A (zh) | 2006-03-15 |
AU2004204804C1 (en) | 2010-11-18 |
AU2004204804B2 (en) | 2010-06-24 |
EP1594513A2 (de) | 2005-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG155054A1 (en) | Human anti- neutralizing antibodies as selective pathway inhibitors | |
ATE399567T1 (de) | Peg konjugate von lhrh analogen | |
SG164369A1 (en) | Human anti-b7rp1 neutralizing antibodies | |
DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
UA85993C2 (ru) | Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего | |
WO2003106659A3 (en) | TOXIN-APTAMER MOLECULES AND METHODS OF USE THEREOF | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
EP2353611A3 (de) | Arzneimittelkonjugate und deren Verwendung zur Behandlung von Krebs, einer Autoimmunerkrankung oder einer Infektionskrankheit | |
NZ592973A (en) | Compositions and methods of using angiopoietin-like 4 protein | |
IL169645A0 (en) | Carbohydrate conjugates fto prevent abuse of controlled substances | |
BR0110530A (pt) | Composições farmacêuticas contendo um antibiótico glicopeptìdico e uma ciclodextrina | |
MY137828A (en) | Keratinocytes which may be used as a biologically active substances for the treatment of wounds | |
GB2431346C (en) | A combination composition comprising paracetamol and ibuprofen | |
EP1978034A4 (de) | Antiperiostin-antikörper und pharmazeutische zusammensetzung zur prävention oder behandlung von mit periostin in zusammenhang stehenden krankheiten, die diese enthält | |
WO2007005941A3 (en) | Liver targeted conjugates | |
DE60027905D1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
DE602006013009D1 (de) | Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs | |
PT1165159E (pt) | Suportes oligossacarídicos para e.g. a remoção de anticorpos do sangue | |
FR2877576B1 (fr) | Composition pharmaceutique utilisee pour stimuler la proliferation et l'activation des mastocytes | |
DE10081194D2 (de) | Darreichungsform zur Applikation in Körperöffnungen | |
TW200806293A (en) | Methods of treatment with CETP inhibitors | |
BRPI0608722A2 (pt) | derivado de pirazolpirimidina ou sal medicinalmente aceitável do mesmo, composição farmacêutica, inibidor de mapkap-k2, e, agente terapêutico | |
FR2839888B1 (fr) | Complexes d'inclusion de fenofibrate et de cyclodextrine et composition pharmaceutique les renfermant | |
ID30249A (id) | Komposisi farmasi untuk terapi gejala-gejala penyakit pelaksanaan fungsi saluran air kencing bawah |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |